Loading…

Left atrial appendage closure with the watchman device reduces atrial fibrillation management costs

Aims To report hospitalization costs of patients with non-valvular atrial fibrillation (AF) submitted to percutaneous left atrial appendage closure (LAAC) with the Watchman device. Methods Pre- and post-procedural hospitalization AF-related costs were calculated using the DRG system (diagnosis-relat...

Full description

Saved in:
Bibliographic Details
Published in:Clinical research in cardiology 2022, Vol.111 (1), p.105-113
Main Authors: D´Ancona, Giuseppe, Safak, Erdal, Weber, Denise, Arslan, Fatih, Kische, Stephan, Darius, Harald, Behrens, Steffen, Zohlenhöfer-Momm, Dietlind, Ortak, Jasmin, Kugler, Joachim, Ince, Hüseyin
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Aims To report hospitalization costs of patients with non-valvular atrial fibrillation (AF) submitted to percutaneous left atrial appendage closure (LAAC) with the Watchman device. Methods Pre- and post-procedural hospitalization AF-related costs were calculated using the DRG system (diagnosis-related groups) and compared. Results Between 2012 and 2016, 677 non-valvular AF patients underwent LAAC. Median time from first cardiac hospitalization to LAAC was 5.9 years (IQR 1.6–9.1) and median follow-up after LAAC was 4.8 years (IQR 3.6–5.6). LAAC mortality was 1.3% and follow-up mortality 16.9%. Median pre-LAAC hospitalization cost was € 17,867 (IQR € 7512–35,08) and post-LAAC € 8772 (IQR € 1183–25,159) ( p  
ISSN:1861-0684
1861-0692
DOI:10.1007/s00392-021-01943-7